跳转至内容
Merck
CN

SML0208

KYP-2047

≥95% (HPLC), Prolyl oligopeptidase inhibitor, oil

别名:

(2S)-1-[[(2S)-1-(1-氧代-4-苯基丁基)-2-吡咯烷基]羰基]-2-吡咯烷腈

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C20H25N3O2
化学文摘社编号:
分子量:
339.43
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥95% (HPLC)
Form:
oil
Quality level:
Storage condition:
desiccated
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

KYP-2047, ≥95% (HPLC)

Quality Level

assay

≥95% (HPLC)

form

oil

storage condition

desiccated

color

white to light brown

storage temp.

2-8°C

SMILES string

O=C(CCCc1ccccc1)N2CCC[C@H]2C(=O)N3CCC[C@H]3C#N

InChI

1S/C20H25N3O2/c21-15-17-10-5-13-22(17)20(25)18-11-6-14-23(18)19(24)12-4-9-16-7-2-1-3-8-16/h1-3,7-8,17-18H,4-6,9-14H2/t17-,18-/m0/s1

InChI key

SPXFAUXQZWJGCJ-ROUUACIJSA-N

Application

KYP-2047可用于脯氨酰内肽酶介导的细胞信号转导研究。

Biochem/physiol Actions

KYP-2047可清除神经细胞氧化应激诱导的α-突触核蛋白聚集体。 α-突触核蛋白是帕金森病中路易小体的主要成分,可引起神经元细胞死亡和痴呆。
KYP-2047是一种非常有效的选择性脯氨酰寡肽酶(POP)抑制剂,也被称为脯氨酰内肽酶(PEP或PE)。 Ki = 0.023 nM(猪)。
KYP-2047是一种非常有效的选择性脯氨酰寡肽酶(POP)抑制剂,也被称为脯氨酰内肽酶(PEP或PE)。Ki = 0.023nM(猪)。在体外已发现KYP-2047对谷氨酸和氧气、葡萄糖剥夺具有神经保护作用。它还被用来抑制AcSDKP从其前体43-mer胸腺素β4(Tβ4)的形成。Ac-SDKP可参与造血干细胞分化,具有促血管生成作用和抗纤维化作用。

Features and Benefits

该化合物是受体分类及信号转导手册上神经肽酶页面上的特色化合物。想要浏览手册的其他页面, 请单击此处


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

We offers many products related to neuropeptidases for your research needs.


Travis W Bainbridge et al.
Scientific reports, 7(1), 12524-12524 (2017-10-04)
Fibroblast Activation Protein (FAP) is a membrane-bound serine protease whose expression is often elevated in activated fibroblasts associated with tissue remodeling in various common diseases such as cancer, arthritis and fibrosis. Like the closely related dipeptidyl peptidase DPPIV, the extracellular
T T Myöhänen et al.
British journal of pharmacology, 166(3), 1097-1113 (2012-01-12)
The aggregation of α-synuclein is connected to the pathology of Parkinson's disease and prolyl oligopeptidase (PREP) accelerates the aggregation of α-synuclein in vitro. The aim of this study was to investigate the effects of a PREP inhibitor, KYP-2047, on α-synuclein
Jianbin Zhang et al.
Life sciences, 270, 119131-119131 (2021-02-01)
Prolyl endopeptidase (PREP) is a serine endopeptidase widely distributed in the body, and accumulated evidence suggests that PREP participates in inflammation and oxidative stress. Here, we explored the effect of PREP gene disruption on hepatic inflammation and oxidative stress status



全球贸易项目编号

货号GTIN
SML0208-5MG04061832982359
SML0208-25MG04061832982342